Has Zoltan Gombos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,335 in general payments to Zoltan Gombos, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Zoltan Gombos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Zoltan Gombos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Zoltan Gombos, MD

Anatomic Pathology & Clinical Pathology · Lafayette, LANPI 1619037595

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,155 of the $4,335 with a category attached, or 72.8%. 10 manufacturers reported payments, led by BD at 43.6% of the total. Reporting peaked in 2023 at $1,904 and has fallen 97.3% since, to $52 in 2025. Among anatomic pathology & clinical pathology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,335in general payments, 2019–2025

Across 36 payments — averaging $120.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

BD$2K
Biomerieux Inc$1K
Abbott$971
Boston Scientific$49
Merck$46
Eisai Inc.$43
plus $112 from 4 others

What the payments were for

Travel & lodging$3,15573%
Food & beverage$1,18027%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
BD	12	$1,891
Biomerieux Inc	6	$1,223
Abbott	7	$971
Boston Scientific	2	$49
Merck	2	$46
Eisai Inc.	2	$43
Genentech USA, Inc.	2	$39
Takeda Pharmaceuticals U.S.A., Inc.	1	$27
Daiichi Sankyo Inc.	1	$25
Cepheid	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Alinity m$882
BD MAX System, BD MAX Instrument$121

How this compares

$4,335 in reported general payments places this provider in the 95th percentile of 132 anatomic pathology & clinical pathology providers in Louisiana.

See all anatomic pathology & clinical pathology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$79,146

Medicare patients

830

Services billed

2,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Lafayette

Josh ShowalterLafayette$494
Kelly SorrellsLafayette$348
Joel CarneyLafayette$341
Tim PetersonNew Orleans$10K
Aaron CotrellShreveport$8K
Tong YangMetairie$7K
Todd LeleuxCrowley$5K
Kim MayhallNew Orleans$1K
Fredric SiskronShreveport$1K
Rusella MirzaShreveport$959

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →